Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Observational Multi Cohort Study of Intranasal MuSE Cell Derived Exosomes, MuSE Stem Cells, and Combination Therapy Delivered Via the Kurve Therapeutics ViaNase Device in Patients Receiving International Regenerative Treatments

NCT07521384 is registered in ClinicalTrials.gov with Healing Hope International as lead sponsor.

NCT NCT07521384
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07521384 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Observational Multi Cohort Study of Intranasal MuSE Cell Derived Exosomes, MuSE Stem Cells, and Combination Therapy Delivered Via the Kurve Therapeutics ViaNase Device in Patients Receiving International Regenerative Treatments
Lead sponsor
Healing Hope International
Phase
Observational
Overall status
Enrolling by invitation
Start date
June 1, 2026
Completion date
January 30, 2029
Enrollment
36 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer dementia (ad), autism, cerebral palsy, hypoxic ischemic encephalopathy, ms (multiple sclerosis), neurologic disorders, parkinson disease (pd), stroke, traumatic brain injury